Indication

Phase

Patients/ Sites

Countries

involved

Stages of study involved

Advanced Colorectal Carcinoma

2b

130/ 10

D, A, F, RU

pre-study visits, site initiation visits, interim monitoring visits and close-out visits

Prostate cancer

2

100/ 8

D, CZ, PL

pre-study visits, site initiation visits

Pain in cancer patients

2

300/ 10

D

pre-study visits

End stage renal disease

4

150/ 12

D

interim monitoring visits and close-out visits

Stroke

3

328/ 30

EU

interim monitoring visits and close-out visits

Treatment of Intracranial Saccular Aneurysms

device

630/ 50

Worldwide

site initiation visits, interim monitoring visits and close-out visits

Prevention of thrombus formation in patients with acute coronary syndrome

2b

800/ 70

US/ EU

pre-study visits, site initiation visits, interim monitoring visits and close-out visits

Secondary Prevention of Atherothrombotic Ischemic Events at stroke, MI and PAD patients

3

19500/ 1032

Worldwide

pre-study visits, site initiation visits

Prevention of blood clot forming in patients hospitalized with chest pain

3

12944/ 600

Worldwide

pre-study visits, site initiation visits, interim monitoring visits

Treatment of Coronary Artery Disease

device

1532/ 160

Worldwide

site initiation visits, interim monitoring visits

Treatment of Coronary Artery Disease

device

1800/ 90

US/ EU

interim monitoring visits

Treatment of Coronary Artery Disease

device

2500/ 30

D, F

site initiation visits, interim monitoring visits and close-out visits

Treatment of Coronary Artery Disease

device

15000/ 500

US/ EU

interim monitoring visits

Treatment of Coronary Artery Disease

´device

532/ 30

US/ EU

interim monitoring visits and close-out visits

Congestive Heart Failure

3

120/ 12

D

pre-study visits

Crohn´s Disease

3

2000/ 60

EU

pre-study visits, site initiation visits, interim monitoring visits and close-out visits

Seasonal Allergic Rhinitis

4

200/ 1

D

site initiation visits, interim monitoring visits and close-out visits

Seasonal Allergic Rhinitis

2

200/ 15

D

pre-study visits

Congestive Heart Failure

3

2016/ 40

EU

Set-up, pre-study visits, site initiation visits, interim monitoring visits and close-out visits

Pulmonary Hypertension*

3

630/ 30

EU

Set-up, pre-study visits, site initiation visits

Anti-Coagulation during Coronary Artery Bypass Grafting*

2

264/ 12

US, D

Set-up

Hypercholesterolemia*

2

60/ 10

D

Set-up, pre-study visits, site initiation visits, interim monitoring visits and close-out visits

Atherosclerosis*

3

400/ 10

EU

interim monitoring visits

COPD*

1

40/ 1

D

Report writing

Arterial Hypertension*

3

600/ 20

EU

interim monitoring visits and close-out visits

Arterial Hypertension*

3

2000/ 30

EU

interim monitoring visits and close-out visits